GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus

被引：0
|
作者：
Claire Greenhill
机构：
[1] Nature Reviews Endocrinology,
来源：
Nature Reviews Endocrinology | 2022年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：331 / 331
相关论文
共 50 条
  • [31] Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats
    F. Palm
    P. Hansell
    G. Ronquist
    A. Waldenström
    P. Liss
    P.-O. Carlsson
    Diabetologia, 2004, 47 : 1223 - 1231
  • [32] In vitro generation of insulin-secreting cells from pancreatic acinar cells of insulin-deficient diabetic animals
    Minami, Kohtar
    Okuno, Masaaki
    Okumaci-H, Akinori
    Miyawaki, Kazumasa
    Yokoi, Norihide
    Seino, Susumu
    DIABETES, 2006, 55 : A361 - A362
  • [33] The Islet Estrogen Receptor-α Is Induced by Hyperglycemia and Protects Against Oxidative Stress-Induced Insulin-Deficient Diabetes
    Kilic, Gamze
    Alvarez-Mercado, Ana I.
    Zarrouki, Bader
    Opland, Darren
    Liew, Chong Wee
    Alonso, Laura C.
    Myers, Martin G., Jr.
    Jonas, Jean-Christophe
    Poitout, Vincent
    Kulkarni, Rohit N.
    Mauvais-Jarvis, Franck
    PLOS ONE, 2014, 9 (02):
  • [34] Addition of a GLP-1 Agonist to Insulin Therapy in Type 2 Diabetes
    Gavigan, Colleen
    Donner, Thomas W.
    DIABETES, 2021, 70
  • [35] Audit of the utility of glucagon like peptide 1 (GLP1) analogues in insulin treated type 2 diabetes
    Ryan, Laura
    O'Connor, Gavin
    Fitzpatrick, Sarah
    Noctor, Eoin
    Melvin, Audrey
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 : S189 - S189
  • [36] Influence of GLP-1 receptor agonist on insulin dosage and blood glucose control of patients with type 2 diabetes mellitus
    Shen, Yimei
    Yang, Xiaohua
    Han, Xiaojun
    Xi, Wei
    Jiang, Lihua
    Wang, Shuqin
    Zhong, Haifeng
    Gu, Yunjuan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (10): : 11814 - 11823
  • [37] Oral GLP1 Gene Delivery by an Antibody-Guided Nanomaterial to Treat Type 2 Diabetes Mellitus
    Hasan, Mohammad Nazmul
    Hwang, Yong Hwa
    An, Jeong Man
    Shahriar, S. M. Shatil
    Cho, Sungpil
    Lee, Yong-Kyu
    ACS APPLIED MATERIALS & INTERFACES, 2020, 12 (35) : 38925 - 38935
  • [38] Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes
    Garg, Vinay
    Verma, Subodh
    Connelly, Kim
    PROGRESS IN CARDIOVASCULAR DISEASES, 2019, 62 (04) : 349 - 357
  • [39] Leptin recruits Creb-regulated transcriptional coactivator 1 to improve hyperglycemia in insulin-deficient diabetes
    Kim, Geun Hyang
    Szabo, Andras
    King, Emily M.
    Ayala, Jennifer
    Ayala, Julio E.
    Altarejos, Judith Y.
    MOLECULAR METABOLISM, 2015, 4 (03): : 227 - 236
  • [40] Insulin degludec is associated with less frequent and milder hypoglycemia in insulin-deficient patients with type 1 diabetes compared with insulin glargine or detemir
    Iwasaki S.
    Kozawa J.
    Kimura T.
    Fukui K.
    Iwahashi H.
    Imagawa A.
    Shimomura I.
    Diabetology International, 2017, 8 (2) : 228 - 236
12345